Decreased expression of p27 has been indicated in many tumors, including lung cancer [17], bladder cancer [18], melanoma [19], and ovarian cancer [20], prostate cancer [21], which was associated with the unfavorable clinical parameters and poor outcomes of these tumors. Here, CDKN1B is linked to lung carcinoma.